{
    "Trade/Device Name(s)": [
        "AllTest Multi-Drug Rapid Test Cup",
        "AllTest Multi-Drug Test Cup"
    ],
    "Submitter Information": "Hangzhou AllTest Biotech Co., Ltd.",
    "510(k) Number": "K244043",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233019"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "PTH",
        "NGL",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "QBF",
        "NGM",
        "QAW",
        "NFW",
        "NGI"
    ],
    "Summary Letter Date": "December 28, 2024",
    "Summary Letter Received Date": "December 30, 2024",
    "Submission Date": "December 28, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3640",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Morphine Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocainemetabolite test system",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Propoxyphene test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Benzodiazepines",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methamphetamine",
        "Methylenedioxymethamphetamine (MDMA)",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Nortriptyline",
        "Marijuana (THC)",
        "Tramadol",
        "Propoxyphene",
        "Fentanyl",
        "6-monoacetylmorphine (6-MAM)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Test cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Antigen-antibody reaction",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Specimen collection device",
        "Multiplex",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for AllTest Multi-Drug Rapid Test Cup and AllTest Multi-Drug Test Cup for qualitative multiplex detection of multiple drugs and drug metabolites in urine via lateral flow immunoassay.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of multiple drugs and their metabolites in human urine for in vitro diagnostic and OTC use; results are preliminary and require confirmatory testing by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}